These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27233470)

  • 1. Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2.
    Hilbers FS; Luijsterburg MS; Wiegant WW; Meijers CM; Völker-Albert M; Boonen RA; van Asperen CJ; Devilee P; van Attikum H
    Hum Mutat; 2016 Sep; 37(9):914-25. PubMed ID: 27233470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare variants in XRCC2 as breast cancer susceptibility alleles.
    Hilbers FS; Wijnen JT; Hoogerbrugge N; Oosterwijk JC; Collee MJ; Peterlongo P; Radice P; Manoukian S; Feroce I; Capra F; Couch FJ; Wang X; Guidugli L; Offit K; Shah S; Campbell IG; Thompson ER; James PA; Trainer AH; Gracia J; Benitez J; van Asperen CJ; Devilee P
    J Med Genet; 2012 Oct; 49(10):618-20. PubMed ID: 23054243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited variants in XRCC2 and the risk of breast cancer.
    Kluźniak W; Wokołorczyk D; Rusak B; Huzarski T; Gronwald J; Stempa K; Rudnicka H; Kashyap A; Dębniak T; Jakubowska A; Lener M; Szwiec M; Tomiczek-Szwiec J; Jarkiewicz-Tretyn J; Cechowska M; Domagała P; Szymiczek A; Bagherzadeh M; Lubiński J; Narod SA; Akbari MR; Cybulski C;
    Breast Cancer Res Treat; 2019 Dec; 178(3):657-663. PubMed ID: 31463769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare, protein-truncating variants in
    Decker B; Allen J; Luccarini C; Pooley KA; Shah M; Bolla MK; Wang Q; Ahmed S; Baynes C; Conroy DM; Brown J; Luben R; Ostrander EA; Pharoah PD; Dunning AM; Easton DF
    J Med Genet; 2017 Nov; 54(11):732-741. PubMed ID: 28779002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
    Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
    Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretic mobility shift assays implicate XRCC2:rs3218550C>T as a potential low-penetrant susceptibility allele for sporadic breast cancer.
    Sirisena ND; Samaranayake N; Dissanayake VHW
    BMC Res Notes; 2019 Aug; 12(1):476. PubMed ID: 31370865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare mutations in XRCC2 increase the risk of breast cancer.
    Park DJ; Lesueur F; Nguyen-Dumont T; Pertesi M; Odefrey F; Hammet F; Neuhausen SL; John EM; Andrulis IL; Terry MB; Daly M; Buys S; Le Calvez-Kelm F; Lonie A; Pope BJ; Tsimiklis H; Voegele C; Hilbers FM; Hoogerbrugge N; Barroso A; Osorio A; ; ; Giles GG; Devilee P; Benitez J; Hopper JL; Tavtigian SV; Goldgar DE; Southey MC
    Am J Hum Genet; 2012 Apr; 90(4):734-9. PubMed ID: 22464251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
    Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
    Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of Missense Variants in XRCC2 by Functional Analysis: Implications for Breast Cancer Association Studies.
    Hansen Tv
    Hum Mutat; 2016 Sep; 37(9):833. PubMed ID: 27516125
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of a Missense Variation (p.S150R:AGC>AGG) in the XRCC2 Gene on Susceptibility to Colorectal Cancer.
    Sadat-Larijani M; Derakhshani S; Keshavarz-Pakseresht B; Nasri-Nasrabadi A; Shirkavand A; Sadat-Shandiz SA; Baghbani-Arani F
    Clin Lab; 2018 Mar; 64(3):233-237. PubMed ID: 29739106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer.
    Rafii S; O'Regan P; Xinarianos G; Azmy I; Stephenson T; Reed M; Meuth M; Thacker J; Cox A
    Hum Mol Genet; 2002 Jun; 11(12):1433-8. PubMed ID: 12023985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for XRCC2 gene polymorphisms in breast cancer risk and survival.
    Lin WY; Camp NJ; Cannon-Albright LA; Allen-Brady K; Balasubramanian S; Reed MW; Hopper JL; Apicella C; Giles GG; Southey MC; Milne RL; Arias-Pérez JI; Menéndez-Rodríguez P; Benítez J; Grundmann M; Dubrowinskaja N; Park-Simon TW; Dörk T; Garcia-Closas M; Figueroa J; Sherman M; Lissowska J; Easton DF; Dunning AM; Rajaraman P; Sigurdson AJ; Doody MM; Linet MS; Pharoah PD; Schmidt MK; Cox A
    J Med Genet; 2011 Jul; 48(7):477-84. PubMed ID: 21632523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
    Hu C; Nagaraj AB; Shimelis H; Montalban G; Lee KY; Huang H; Lumby CA; Na J; Susswein LR; Roberts ME; Marshall ML; Hiraki S; LaDuca H; Chao E; Yussuf A; Pesaran T; Neuhausen SL; Haiman CA; Kraft P; Lindstrom S; Palmer JR; Teras LR; Vachon CM; Yao S; Ong I; Nathanson KL; Weitzel JN; Boddicker N; Gnanaolivu R; Polley EC; Mer G; Cui G; Karam R; Richardson ME; Domchek SM; Yadav S; Hruska KS; Dolinsky J; Weroha SJ; Hart SN; Simard J; Masson JY; Pang YP; Couch FJ
    Cancer Res; 2023 Aug; 83(15):2557-2571. PubMed ID: 37253112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
    Tervasmäki A; Mantere T; Hartikainen JM; Kauppila S; Lee HM; Koivuluoma S; Grip M; Karihtala P; Jukkola-Vuorinen A; Mannermaa A; Winqvist R; Pylkäs K
    Int J Cancer; 2018 Jun; 142(11):2286-2292. PubMed ID: 29341116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of XRCC2 with breast cancer, a multi-omics analysis at genomic, transcriptomic, and epigenomic level.
    Gilani N; Ozaslan M
    Cell Mol Biol (Noisy-le-grand); 2024 Jul; 70(7):252-259. PubMed ID: 39097872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Variant Screening of DNA Repair Genes in Myelodysplastic Syndrome Identifies a Novel Mutation in the XRCC2 Gene.
    Valka J; Vesela J; Votavova H; Dostalova-Merkerova M; Urbanova Z; Jonasova A; Cermak J; Belickova M
    Oncol Res Treat; 2019; 42(5):263-268. PubMed ID: 30861523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic gene-gene and gene-environment interaction analysis of DNA repair genes XRCC1, XRCC2, XRCC3, XRCC4, and oral cancer risk.
    Yang CH; Lin YD; Yen CY; Chuang LY; Chang HW
    OMICS; 2015 Apr; 19(4):238-47. PubMed ID: 25831063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.
    Yu KD; Chen AX; Qiu LX; Fan L; Yang C; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.
    Michalska MM; Samulak D; Romanowicz H; Smolarz B
    Pathol Oncol Res; 2015 Sep; 21(4):935-40. PubMed ID: 25743260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.